loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Germany-Ludwigshafen: Pharmaceutical products

World Biggest Tenders Source

This tender with title Germany-Ludwigshafen: Pharmaceutical products has been published on Bidding Source portal dated 24 Feb 2018 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Germany-Ludwigshafen: Pharmaceutical products
Contract notice
2018/S 039-084796
Germany
Germany-Ludwigshafen
24 Feb 2018
1 Jan 2020
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion not excluding pharmaceutical discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient budesonide (ATC code according to WHO: A07EA06) - 294793-2024 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V with the active ingredient Ranibizumab - 297446-2024 Germany Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for medicines with the active ingredient pomalidomide (ATC code: L04AX06). - 294579-2024 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient bismuth subcitrate, tetracycline and metronidazole (A02BD08) within the framework of a so-called open-house model. - 295823-2024 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient lipegfilgrastim (L03AA14) within the framework of a so-called open-house model. - 297151-2024 Germany Conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient aclidinium bromide (ATC code according to WHO: R03BB05) - 294575-2024 Germany Conclusion not excluding pharmaceutical discount agreement. according to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient combination formoterol/glycopyrronium/budesonide (ATC code according to WHO: R03AL11) - 294968-2024 Germany Conclusion of a non-exclusive discount agreement pursuant to Section 130a Para. 8 SGB V for the active ingredient Rituximab - 295273-2024 Germany Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient Follitropin alfa (G03GA05) within the framework of a so-called open house model. - 294468-2024 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient ganirelix (H01CC01) within the framework of a so-called open-house model. - 294895-2024 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans